NeoGenomics Laboratories Revenue and Competitors

Fort Myers, FL USA

Location

$350.5M

Total Funding

Estimated Revenue & Valuation

  • NeoGenomics Laboratories's estimated annual revenue is currently $579.1M per year.(i)
  • NeoGenomics Laboratories received $150.0M in venture funding in December 2016.
  • NeoGenomics Laboratories's estimated revenue per employee is $386,100
  • NeoGenomics Laboratories's total funding is $350.5M.

Employee Data

  • NeoGenomics Laboratories has 1500 Employees.(i)
  • NeoGenomics Laboratories grew their employee count by 10% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$127.6M37812%N/AN/A
#2
$77.8M2625%N/AN/A
#3
$21.9M8121%N/AN/A
#4
$66.5M224-3%N/AN/A
#5
$271.8M7198%N/AN/A
#6
$60.3M20321%N/AN/A
#7
$110.7M328N/AN/AN/A
#8
$197.1M5846%N/AN/A
#9
$290.3M7686%N/AN/A
#10
$34.8M1297%N/AN/A
Add Company

NeoGenomics Laboratories is a leading cancer diagnostic reference laboratory that has provided high-quality cancer testing and partnership programs to pathologists and oncologists for over 10 years. We work every day to achieve our common purpose of saving lives by improving patient CARE through Communication, Accuracy, Reliability, and Efficiency. Our areas of expertise include cancer cytogenetics with industry-leading turnaround times; hematologic and solid tumor FISH testing with the largest menu of technical-only services available; 10-color flow cytometry; IHC supported by an extensive antibody library; and over 100 molecular oncology tests comprising the most comprehensive combination of multiparameter profiles and targeted biomarker tests in the industry. Our technical-only testing programs feature on-demand or live training and are available to pathologists who wish to sign out FISH, flow cytometry, and/or IHC. NeoGenomics extremely fast test development cycle means we are highly responsive to therapy development and guideline changes, and test design always involves a balance of convention and innovation. We support clients in many cancer-related market segments, to include: hospital and private pathology laboratories, office-based oncologists, CRO / Biopharmaceutical development organizations, academic institutions / teaching hospitals, and several more. CONNECT WITH US Online: neogenomics.com Twitter: https://twitter.com/NeoGenomics Facebook: facebook.com/neogenomics

keywords:Biotechnology,Healthcare,Healthcare Providers,Medical Diagnostics,Pharmaceuticals

$350.5M

Total Funding

1500

Number of Employees

$579.1M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

NeoGenomics Laboratories's People

NameTitleEmail/Phone
1
Director or GeneticsReveal Email/Phone
2
Director HematopathologyReveal Email/Phone
3
SVPReveal Email/Phone
4
Chief Technology OfficerReveal Email/Phone
5
Global Director Anatomic Pathology Operations, Pharma Servises, at NeoGenomics LaboratoriesReveal Email/Phone
6
Senior Pathologist/HematopathologistReveal Email/Phone
7
Chief Financial OfficerReveal Email/Phone
8
Project ManagerReveal Email/Phone
9
Regional Director, Great LakesReveal Email/Phone
10
Cytogenetics Lead TechnologistReveal Email/Phone

NeoGenomics Laboratories News

2022-04-20 - NeoGenomics Reports Revenue of $117 Million in the First ...

said Lynn Tetrault, Executive Chair of NeoGenomics. ... CAP accredited and CLIA certified laboratories in Fort Myers and Tampa, Florida;...

2022-04-20 - NeoGenomics: Q1 Earnings Snapshot

The operator of cancer-focused testing laboratories posted revenue of $117.2 million in the period, also exceeding Street forecasts.

2022-04-06 - NeoGenomics, Inc. Expands Its Global Strategic Partnership ...

This partnership strengthens NeoGenomics' proteomics-based product ... Pharma Services, NeoGenomics Laboratories, Inc. "Partnering with...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$300M16653%N/A
#2
$716.6M22551%N/A
#3
$614.4M2438N/AN/A
#4
$1151.7M36242%N/A
#5
$1698M67383%N/A

NeoGenomics Laboratories Funding

DateAmountRoundLead InvestorsReference
2003-04-16$1.5MDebt FinancingMedical Venture PartnersArticle
2005-03-30$1.5MUndisclosedAspen Select Healthcare LPArticle
2006-01-26$0.6MUndisclosedArticle
2007-06-08$8.0MUndisclosedWachovia BankArticle
2013-03-01$9.5MUndisclosedCraig-Hallum Capital Group LLCArticle
2014-08-25$34.6MUndisclosedWilliam Blair & Company, L.L.C.Article
2016-12-23$150.0MUndisclosedArticle